Paul Alan Brooke

Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom.

Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin.